The Latest Cardiac and Vascular News
Adaptive and efficient trial design may allow for expedited development timeline while maintaining scientific rigor WALTHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE) today presents the design of IMPAHCT (Inhaled iMatinib for Pulmonary Arterial Hypertension Clinical Trial; AV-101-002), a Phase 2b/Phase 3 trial investigating the […]
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced it has appointed Alexey (Alex) Nepogodiev as Executive Vice President, Global Marketing. Alex possesses more than 20 years of leadership experience in successfully developing new markets and therapies in interventional cardiology, structural heart, and endovascular businesses worldwide. […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its at-the-market (ATM) facility, raising gross proceeds of $7.6 million. The Company sold 1,072,246 shares of common stock at a weighted average price of $7.09 per share, as adjusted for a reverse […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday. In his more than 30 years in the medical technology arena, Mr. Casciaro has developed a track record of success leading and growing both private and […]
IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that a study assessing its MobiusHD device to treat patients with chronic heart failure has been published in the peer-reviewed journal, Structural Heart. The findings and […]
Issuance of convertible bonds into shares for an amount of €3.9 M to historical shareholders Issuance of simple bonds with attached warrants to a new French investor for €2.0 M PARIS–(BUSINESS WIRE)–Regulatory News: Acticor Biotech (Euronext Growth Paris – ISIN : FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing an […]
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Confluent Medical Technologies, Inc. (“Confluent”) today announced that Matthew K. Eckl has been appointed as Chief Financial Officer (“CFO”) for the company, effective October 17, 2022. “We are thrilled to welcome Matt to Confluent,” said Dean Schauer, Confluent’s Chief Executive Officer. “Matt has exceptional experience in finance and […]
Clinical results confirm hemocompatibility and show absence of inflammation after Aeson® implant, with significant potential benefits for patients PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the full market release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems (2.00 Max Crown). Built on the […]
Smaller Sheath Simplifies Access and Improves Ease-of-Use DANVERS, Mass.–(BUSINESS WIRE)–The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed (Nasdaq: ABMD) for its Impella Low Profile Sheath. Compared to the existing 14 French (Fr) sheath used for placement of Impella CP, the new sheath maintains the same inner […]
